1405 RESEARCH BLVD, SUITE 125, ROCKVILLE, MD
Announces Initiation of Strategic Review to Maximize Shareholder Value
Investor Presentation
Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
News, Articles of Incorporation
Shareholder votes
Reports First Quarter 2025 Financial Results and Updates on Clinical Progress
Annual Report to Security Holders
Q2
Q1
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Registration of Securities
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
S-1MEF